Vol. 26 No. 1 (2025)

Original research

• [Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-per-Responder Analysis]

  Paolo Gisondi, Andrea Chiricozzi, Marcello Pani, Massimiliano Povero, Luca Castello, Maria Paola Pedone, Kerry Noonan, Zhixiao Wang, Roberta Di Turi

  • HTML
  • PDF

• Retifanlimab Vs Avelumab in Patients with Metastatic Merkel Cell Carcinoma: A Cost Utility Analysis in Italy

  Gianni Ghetti, Camilla Porta, Massimiliano Povero

  • HTML
  • PDF

• Real-World Outcomes of Single-Inhaler Triple Therapy Prescribed by General Practitioners in Managing Chronic Obstructive Pulmonary Disease: A Systematic Literature Review

  Linet Odonde, Lorenzo Pradelli, Claudio Micheletto

  • HTML
  • PDF

• Therapeutic Journey and Economic Burden of Patients with Myasthenia Gravis in Italy: Results of a Real-World Analysis

  Valentina Perrone, Stefania Mazzoni, Maria Cappuccilli, Margherita Andretta, Marcello Bacca, Antonietta Barbieri, Fausto Bartolini, Alessandro Chinellato, Andrea Ciaccia, Alberto Costantini, Francesco De Vita, Stefania Dell'Orco, Fulvio Ferrante, Simona Gentile, Stefano Grego, Daniela Mancini, Marzia Mensurati, Rossella Moscogiuri, Romina Pagliaro, Nicola Petragnani, Cataldo Procacci, Davide Re, Fiorenzo Santoleri, Michele Giuseppe Tari, Loredana Ubertazzo, Carlo Giuseppe Antozzi, Luca Degli Esposti

  • HTML
  • PDF